Human Holotranscobalamin (Holo TC) ELISA Kit

• Catalog Number: orb1736604
• Category: Assays and Kits
• Description: This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Human Holo TC protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human Holo TC. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human Holo TC in the samples is then determined by comparing the OD of the samples to the standard curve.
• Reactivity: Human
• Concentration: 10 ng/mL
• Application notes: standard: 10 ng/mL. Test principle: This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Human Holo TC protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human Holo TC. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human Holo TC in the samples is then determined by comparing the OD of the samples to the standard curve
• Assay Time: 2.5h
• Range: 0.16-10 ng/mL
• Sensitivity: 0.045 ng/mL
• Sample Types: serum, plasma and other biological fluids
• Alternative names: Holo-TC
• Note: For research use only

References

Lingmiao Wang 1, Ailin Guo 2, Shuang Liang 3, Lingling Yu 3, Bai Shen 4, Zhihang Huang The association of serum hsa-miR-21-5p expression with the severity and prognosis of heart failure with reduced ejection fraction BMC Cardiovasc Disord, (2025)

PubMed: 39972425

Applications

ELISA

Reactivity

Human